TNF Pharma raises $7M, acquires LPU Holdings for crypto mining, ends sarcopenia trial

Q/C TECHNOLOGIES, INC.

$7M private placement: Series H convertible preferred (7% dividend, $5 conversion) and warrants for 1.4M shares at $5; expected close Sept 4, 2025.
Agrees to acquire LPU Holdings for Series I convertible preferred convertible into 747,362 shares at $0.001/sh; contingent milestones; license with LightSolver for crypto mining laser hardware.
Terminates Master Service Agreement with Prevail for Phase 2 sarcopenia/frailty trial; effective 30 days after Sept 2, 2025 notice.
Director changes: Uzonwanne resigns; Glass steps down as President (stays CMO/Board); Bernstein appointed to Board; Silverman named Executive Chairman.

item 1.01 item 1.02 item 3.02 item 3.03 item 5.03 item 5.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Q/C TECHNOLOGIES, INC.: Filed Certificate of Amendment to Certificate of Incorporation to effect a 1-for-100 reverse stock split of Common Stock (effective 2025-08-29).

Change: charter amendment
Effective: 2025-08-29

Exact text from the filing

On August 29, 2025, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) to the Certificate of Incorporation of the Company (the “Certificate of Incorporation”) with the Secretary of State of Delaware to effect a 1-for-100 reverse stock split of the shares of the Company’s Common Stock either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (New York time) on August 29, 2025 (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

Q/C TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-026167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.